Skip to content
Disclosery

EXANE DERIVATIVES: META position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on META, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8,517 META shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8,517 shares
    Change vs previous 13F +1,420 shares

    0.79% of the 13F portfolio, value $1,373,063.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 7,097 shares
    Change vs previous 13F +759 shares

    0.44% of the 13F portfolio, value $1,577,970.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,338 shares
    Change vs previous 13F +1,821 shares

    0.52% of the 13F portfolio, value $2,131,680.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,517 shares
    Change vs previous 13F +442 shares

    0.38% of the 13F portfolio, value $1,532,949.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,075 shares
    Change vs previous 13F -163 shares

    0.34% of the 13F portfolio, value $1,434,722.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,238 shares
    Change vs previous 13F +656 shares

    0.38% of the 13F portfolio, value $1,248,142.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,582 shares
    Change vs previous 13F +3,129 shares

    0.3% of the 13F portfolio, value $978,398.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 453 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $118,636.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).